24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Ibuprofen, Similar Painkillers Won't Raise Risks for COVID PatientsObesity Raises Odds for Many Common CancersAsthma Attacks Plummeted During PandemicWhy Sleep Raises Risk for Sudden Death in People With EpilepsyLockdown Loneliness Making Things Even Tougher for Cancer PatientsCOVID Vaccines May Still Leave Organ Transplant Recipients UnprotectedPfizer, Moderna or J&J? An Expert Answers Your QuestionsHow Summer Camps Can Shield Your Kids from Allergies, Asthma & COVIDCould Your Child Have a Heart Defect? Know the Warning SignsGene Tied to Balding May Also Raise COVID Risks for MenTime Spent in ICU Linked to Higher Odds for Suicide LaterState of Mind Matters for Survival After Heart AttackFailing Kidneys Could Bring Higher Dementia RiskAir Pollution Can Harm Kids' Hearts for a LifetimePoll Finds Many Parents Hesitant to Get Younger Kids VaccinatedObesity More Deadly for Men Than Women When COVID StrikesIsrael Study: Pfizer Vaccine Gives 95% Protection Against Illness, Hospitalization & DeathReal-World Studies Show Pfizer Vaccine Shields Against COVID Variants1 in 4 U.S. Teens Has Had a Concussion: StudyWhat's the Right Amount of Sleep for a Healthy Heart?U.S. COVID Outlook Shows Big Improvement by July'Prediabetes' Raises Odds for Heart Attack, StrokeA Vitamin Could Be Key to Women's Pain After Knee ReplacementBiden Sets New Goal of Vaccinating 70% of Americans by July 4Wildfires Are Changing the Seasonal Air Quality of the U.S. WestMany Americans Wrong About Sun's Skin Cancer Dangers: PollNot Just About Antibodies: Why mRNA COVID Vaccines May Shield From VariantsYou Got Your COVID Shot: What to Do With That Vaccine CardFDA Plans to OK Pfizer Vaccine for Those Aged 12 and UpAHA News: As Pre-Pandemic Activities Return, So Does AnxietyCOVID Anxieties Still High for Americans: PollCOVID Vaccination in Pregnancy May Pass Helpful Antibodies to BabyWhy U.S. Hispanics Got COVID at Higher Rates: Their JobsHerd Immunity for Americans May Be an Elusive Goal, Experts SayUrgent Care or the ER? Which Should You Choose?Needle Anxiety Behind J&J COVID Vaccine Reaction Clusters: Study1 in 5 Patients on Kidney Dialysis Say No to COVID-19 Vaccine: StudyYoung, Immune-Compromised Patients Are Hotspots for Coronavirus Mutations: StudyYour Blood Type Might Raise Odds for Certain Health ConditionsCOVID Deaths Continue to Decline in U.S.Researchers Seek Antiviral Pill That Would Ease COVID SeverityAHA News: Take Stock of Your Health With This Post-Lockdown ChecklistPoll Reveals Who's Most Vaccine-Hesitant in America and WhyGood Stroke Recovery May Depend on Your ZIP Code: StudyNew Advice for Blood Pressure That's a Bit Too HighCOVID-19 and Advanced Diabetes Can Be a Deadly Mix: StudyMany U.S. Colleges Will Mandate Vaccines on Campus Next Fall: SurveyPfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at SecondAbout 1 in 7 Who Get Pfizer Vaccine Will Have Any 'Systemic' Side Effect: StudyPolls Find Most U.S. Young People Take COVID Threat Seriously
Questions and AnswersLinks
Related Topics

Diabetes

Exoskeleton Helps Paralyzed People Walk Again

HealthDay News
by Cara Murez
Updated: Nov 18th 2020

new article illustration

WEDNESDAY, Nov. 18, 2020 (HealthDay News) -- People paralyzed with spinal cord injuries can safely and effectively use an exoskeleton to assist them in walking, a new study finds.

"Participants showed improvement regardless of level of injury, completeness or duration of injury," said Gail Forrest, director of the Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation in East Hanover, N.J.

The findings suggest "that exoskeletons can be used to improve mobility across a broad spectrum of individuals with neurological deficits caused by spinal cord injury," she said in a foundation news release.

The randomized clinical trial included 50 participants with paralysis either in the lower body or in both the upper and lower body. This included people with no motor function as well as those who'd still retained some movement ability.

Two groups did either exo-assisted walking or usual activity for 12 weeks, then switched. Their performance was measured over 12, 24 and 36 sessions using three tests: a timed 10-meter walk; a six-minute walk; and a timed test in which patients get up from a seated position, walk a set distance, turn around, walk back and sit down.

The researchers used two powered exoskeletons in the study: the Ekso GT (Ekso Bionics), and ReWalk (ReWalk Robotics). The findings were published earlier this year in the journal Frontiers in Robotics and AI.

The aim was to establish guidelines for clinical exoskeletal-assisted walking programs for patients with spinal cord injury. The researchers also hoped to determine how many training sessions were needed to equip individuals with assisted walking skills and then to reach speed goals.

The majority of participants mastered the ability to move with the assistance of the exoskeleton, Forrest said.

After 12 sessions, 62%, 70% and 72% of participants achieved the milestones for the three walking tests, respectively. After 36 sessions, 80%, 82% and 84% did so, the findings showed.

According to Forrest, the results can be used to "guide the application of exoskeletons to spinal cord injury rehabilitation."

More information

The American Society of Mechanical Engineers offers additional information on the use of robotics in medicine.

SOURCE: Kessler Foundation, news release, Nov. 12, 2020